Today: 3 July 2026

SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

London, 09:35 GMT, February 4, 2026 — Regular session SSE Plc shares climbed 1.3% to 2,467 pence in early London trading Wednesday after the power utility lowered its full-year earnings forecast, blaming mixed weather conditions. The Perth, Scotland-based company now expects adjusted earnings per share of 144-152 pence for 2025/26, down from 160.9p last year. RBC Capital Markets noted the midpoint of 148p was slightly below Bloomberg’s consensus of 149.9p.
4 February 2026
··
BT completes Radianz sale to TNS as BT shares push above 200p and dividend debate heats up

BT completes Radianz sale to TNS as BT shares push above 200p and dividend debate heats up

BT Group said it has completed the sale of its Radianz business to Transaction Network Services, handing over a unit that provides connectivity used by financial-market firms. BT said the transaction, agreed in September, received regulatory clearances. TNS said Radianz will fold into its Financial Markets offering, widening access to trading venues, market data and applications for institutional clients. Tom Lazenga, general manager of TNS Financial Markets, called it an “important milestone” as the two networks combine.
4 February 2026
··
Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich Insurance Group has struck outline terms for an about 8 billion pound cash takeover of FTSE 100 underwriter Beazley, with Beazley saying it would be minded to recommend the offer if Zurich turns it into a firm bid by Feb. 16. The talks matter now because the UK Takeover Code forces a bidder into a near-term decision: Zurich must either publish a formal offer by a set deadline or step back. For Zurich, the prize is a deeper push into specialty insurance — cover for complex risks such as cyber, marine and aviation — and a bigger footprint through Lloyd’s of London.
4 February 2026
·····
RBI gives Yes Bank’s CEO pick the green light: Vinay Tonse set for top job

RBI gives Yes Bank’s CEO pick the green light: Vinay Tonse set for top job

Yes Bank announced in a stock exchange filing that India’s central bank has given the green light to Vinay Muralidhar Tonse as its new managing director and CEO. He will serve a three-year term. https://www.reuters.com/sustainability/boards-policy-regulation/indias-rbi-approves-appointment-vinay-muralidhar-tonse-md-ceo-yes-bank-2026-02-04/ The move comes as Yes Bank works to regain stability following a turbulent stretch that led to a lender-led bailout in 2020 and a shift in its shareholder lineup last year. In 2025, Japan’s Sumitomo Mitsui Banking Corporation acquired a 24% stake in the Mumbai-based lender. https://www.vccircle.com/formersbi-exec-to-take-over-as-smbc-backed-yes-bank-s-new-md-ceo
4 February 2026
·
BAE Systems share price ticks up as Ukraine air-defence buy, $195m US Marines order and buyback hit tape

BAE Systems share price ticks up as Ukraine air-defence buy, $195m US Marines order and buyback hit tape

London, Feb 4, 2026, 09:15 GMT — Regular session BAE Systems shares inched up early Wednesday in London as investors weighed new contract news linked to Ukraine aid and U.S. defence budgets. The stock rose roughly 0.1% to 1,933.5 pence, swinging between 1,919.5 and 1,940.5 during the session. It continues to trade within a 52-week range of 1,171 to 2,159.
4 February 2026
·
Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk shares dropped sharply on Wednesday after the Danish pharmaceutical giant flagged a potential 13% decline in sales and profit for 2026, marking a notable reversal for the company behind weight-loss drug Wegovy and diabetes treatment Ozempic. Early trading in Copenhagen saw shares plunge 18%, according to the Financial Times. https://www.ft.com/content/d148ce25-fa76-468b-b9ac-95c62a994a55 The outlook is crucial since Novo is at the heart of the obesity-drug surge, but it now signals the easy-growth phase has ended. U.S. politics and payer resistance are creeping into guidance, even as competitors ramp up pricing and fight for market share.
4 February 2026
···
Standard Chartered share price climbs ahead of BoE as STAN.L hovers near 52-week high

Standard Chartered share price climbs ahead of BoE as STAN.L hovers near 52-week high

London, Feb 4, 2026, 09:06 GMT — Regular session Standard Chartered shares climbed on Wednesday, holding near the upper end of their recent range as investors weighed central bank risks against a weak mood in European stocks. Around 09:05 GMT, the stock was up roughly 1.2% at 1,901.5 pence, after closing at 1,879.0 pence the day before. Trading during the session fluctuated between 1,888.5 and 1,910.0 pence.
4 February 2026
··
1 … 560 561 562 563 564 … 2,134

Stock Market Today

  • UK REITs Post Mixed Moves on M&A, SEGRO Jumps, Others Lag in June
    July 3, 2026, 6:28 AM EDT. UK REITs traded unevenly in June as M&A news drove some sharp moves. The sector added 1.5% for the month and 4.5% for the quarter but still fell 5.4% over the first half of 2024 with investors watching inflation and geopolitics. SEGRO climbed more than 20% after it rejected a bid from Prologis, saying the offer undervalued the company. Tritax Big Box and Schroder European REIT also rose, each citing progress on projects or wind-down plans. Ground Rents Income Fund underperformed as leasehold reform and a 40% NAV drop weighed. Alternative Income REIT slipped after receiving a low takeover approach. M&A deals and shifting portfolios set the tone for the sector during the month.
Go toTop